Supplemental Disclosures for the Statement of Consolidated Cash Flows (Tables)

3 Months Ended

Mar. 31, 2023

Supplemental Cash Flow Elements [Abstract]

Schedule of Certain Non-cash Investing and Financing Activities

Certain non-cash investing and financing activities for the three months ended March 31, 2023 and 2022 (in thousands) are outlined below:

	Three Months Ended
	March 31, 2023		March 31, 2022
Accrued capital expenditures and deferred lease costs	$	15,709	$	15,557
Change in accrued dividends	$	(25,358)	$	(26,048)
Accrued deferred financing costs	$	53	$	—

The following table provides a reconciliation of cash, cash equivalents, and restricted cash and escrows as presented in the accompanying consolidated statements of cash flows for the three months ended March 31, 2023 and 2022, to the consolidated balance sheets for the respective period (in thousands):

	2023		2022
Cash and cash equivalents, beginning of period	$	16,536	$	7,419
Restricted cash and escrows, beginning of period	3,064		1,441
Total cash, cash equivalents, and restricted cash and escrows as presented in the accompanying consolidated statement of cash flows, beginning of period	$	19,600	$	8,860
Cash and cash equivalents, end of period	$	170,593	$	7,211
Restricted cash and escrows, end of period	4,183		1,457
Total cash, cash equivalents, and restricted cash and escrows as presented in the accompanying consolidated statement of cash flows, end of period	$	174,776	$	8,668